A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
16h
GlobalData on MSNFDA grants breakthrough designation for Acrivon’s endometrial cancer assayThe US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results